Clinical Trials Directory

Trials / Completed

CompletedNCT03999476

Evaluation of the Efficacy of Ambu® aScope for Intubation in Cancer Tongue

Randomized- Single Blind Trial of Ambu Ascope and Fiberoptic in Severely Difficult Air Way Patient Having Posterior Third Fixed Tongue Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
mahmoud salem soliman · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study compares the ascope with standard fiberscope using the nasal route of intubation in patient having sever difficult airway (having posterior one third cancer tongue with fixed mobility)

Detailed description

patient will be allocated into two group according to the type of endoscope used group (F) fibro scope group and group (A) the ambu ascope group The timer will be started (T0), when touching the fiberscope or a scope. The standard fiberscope or a scope2 will be introduced through the nostril and advanced through the vocal cords, once carina identified the time will be recorded ( T1) When correct positioning of the trachea confirmed by detection of the end-tidal co2 curve on capnography (T2).

Conditions

Interventions

TypeNameDescription
DEVICEambu ascopenasal route intubation by the device in fixed cancer tongue patients
DEVICEfibreroptic bronchoscopenasal route intubation by the device in fixed cancer tongue patients

Timeline

Start date
2018-08-01
Primary completion
2020-05-05
Completion
2020-05-19
First posted
2019-06-26
Last updated
2022-10-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03999476. Inclusion in this directory is not an endorsement.